Xoma Technology Ltd.

Other

Alere San Diego, Inc.

Biosite Incorporated

Unisyn Technologies, Inc.

Unisyn Fibertec Corporation

Uday Kumar Veeramallu

Jeff Gray

Joe Buechler

Joseph Buechler

Seok-Won Lee

Timothy C Gebhard

Kelline Marie Rodems

Paul H McPherson

Gunars E Valkirs

William D Arnold

Scott Rongey

Jonathan Gary

Brian Noland

Vance Wong

David W Oelschlager

Christelle Jost

Scott Harold Rongey

The present invention relates in part to diagnosing the occurrence of heart failure, particularly in subjects who exhibit a normal body fluid level of a natriuretic peptide. The present invention further relates in part to assigning an outcome risk (e.g., worsening cardiac function or a mortality risk, a risk of rehospitalization) to a subject. The methods comprise performing one or more assays that detect one or more biomarkers selected from the group consisting of WAP4C, ESAM, LTBR, Mesothelin, and Syndecan-1 performed on a body fluid sample obtained from a subject, and assigning diagnosis or risk based, at least in part, on the result(s) obtained thereby.

Methods and compositions for diagnosis and risk prediction in heart failure

The present invention generally relates to methods and compositions for expressing proteins or polypeptides in prokaryotic hosts using eukaryotic signal sequences.

Eukaryotic signal sequences for polypeptide expression and polypeptide display libraries

The present invention relates to methods and compositions for diagnosing SIRS, sepsis, severe sepsis, septic shock, or MODS in a subject, or assigning a prognostic risk for one or more clinical outcomes for a subject suffering from SIRS, sepsis, severe sepsis, septic shock, or MODS, the method comprising performing an immunoassay for CCL23 splice variant.

Methods and compositions for diagnosis and/or prognosis in systemic inflammatory response syndromes

The present invention relates to methods and compositions for measuring latent protein C in test samples, particularly patient samples. The methods and compositions described are sensitive for latent protein C, relative to activated protein C.

Latent protein C assays and their uses for diagnosis and/or prognosis in systemic inflammatory response syndromes

Eukaryotic signal sequences for prokaryotic expression

A unique hollow fiber multiple bioreactor system and method for the propagation of cells and the production of various cell propagation products is described. Simultaneous fluid flow through lumens of hollow fibers in bioreactors is maintained constant across multiple bioreactors so production is maintained essentially constant. The system and method include use of a flow block holder which allows a dissolved oxygen probe to be calibrated at the same pressure as the media in the bioreactor system.

Multi-bioreactor hollow fiber cell propagation system and method

A unique hollow fiber bioreactor system and method for the propagation of cells and the production of various cell propagation products is described. The system and method include the use of a flow block holder which allows a dissolved oxygen probe to be calibrated at the same pressure as the media in the bioreactor system.

Hollow fiber cell propagation system and method

Growing community of inventors

San Diego, CA, United States of America

Uday Kumar Veeramallu